These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis. Hodsman A, Adachi J, Olszynski W. CMAJ; 1996 Oct 01; 155(7):945-8. PubMed ID: 8837544 [Abstract] [Full Text] [Related]
5. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis. Murray TM, Ste-Marie LG. CMAJ; 1996 Oct 01; 155(7):949-54. PubMed ID: 8837545 [Abstract] [Full Text] [Related]
7. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis. Siminoski K, Josse RG. CMAJ; 1996 Oct 01; 155(7):962-5. PubMed ID: 8837547 [Abstract] [Full Text] [Related]
8. Comparative cardiovascular effects of different progestins in menopause. Rosano GM, Fini M. Int J Fertil Womens Med; 2001 Oct 01; 46(5):248-56. PubMed ID: 11720197 [Abstract] [Full Text] [Related]
12. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR, Gadducci A, Gambacciani M. Climacteric; 2001 Sep 01; 4(3):181-93. PubMed ID: 11588941 [Abstract] [Full Text] [Related]
13. Hormone replacement therapy and cancer. Gynecol Endocrinol; 2001 Dec 01; 15(6):453-65. PubMed ID: 11826770 [Abstract] [Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS. Oncologist; 1996 Dec 01; 1(5):326-330. PubMed ID: 10388011 [Abstract] [Full Text] [Related]
15. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C. J Endocrinol Invest; 2005 Dec 01; 28(10 Suppl):80-4. PubMed ID: 16550729 [Abstract] [Full Text] [Related]
16. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Stefanick ML. Am J Med; 2005 Dec 19; 118 Suppl 12B():64-73. PubMed ID: 16414329 [Abstract] [Full Text] [Related]
17. HRT dosing regimens: continuous versus cyclic-pros and cons. Shoupe D. Int J Fertil Womens Med; 2001 Dec 19; 46(1):7-15. PubMed ID: 11294619 [Abstract] [Full Text] [Related]
18. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. North American Menopause Society. Menopause; 2006 Dec 19; 13(3):340-67; quiz 368-9. PubMed ID: 16735931 [Abstract] [Full Text] [Related]
19. Contraception for the perimenopausal patient. Upton GV. Obstet Gynecol Clin North Am; 1987 Mar 19; 14(1):207-27. PubMed ID: 3306520 [Abstract] [Full Text] [Related]
20. Use of low-dosage 17 beta-estradiol for the prevention of osteoporosis. Ettinger B. Clin Ther; 1993 Mar 19; 15(6):950-62; discussion 949. PubMed ID: 8111815 [Abstract] [Full Text] [Related] Page: [Next] [New Search]